RRE Ventures Acquisition Corp.·4

May 5, 4:30 PM ET

Epstein Jeffrey Douglas 4

4 · RRE Ventures Acquisition Corp. · Filed May 5, 2026

Research Summary

AI-generated summary of this filing

Updated

RRE Ventures (RREV) President Jeffrey D. Epstein Receives Awards

What Happened

  • Jeffrey Douglas Epstein, President and Director of RRE Ventures Acquisition Corp. (RREV), reported three awards/acquisitions of derivative securities. He was granted 450,000 units on 2026-03-02 and 150,000 units on 2026-03-18 at $0.00 each (no cash paid), and a 500,000-unit award on 2026-05-01 at $1.00 each (total cash value $500,000). All reported transactions are classified as derivative securities (awards), not open-market purchases or sales.

Key Details

  • Transaction dates and prices:
    • 2026-03-02: 450,000 units @ $0.00 (award)
    • 2026-03-18: 150,000 units @ $0.00 (award)
    • 2026-05-01: 500,000 units @ $1.00 (award) — $500,000 total
  • Total units acquired (all awards): 1,100,000
  • Shares owned after transactions: Not specified in the provided excerpt of the filing.
  • Footnotes of note:
    • F1: Class B ordinary shares convert one-for-one into Class A ordinary shares at the issuer's initial business combination (or earlier at the holder’s option) and have no expiration date.
    • F2: Some of these securities were previously reported on the Reporting Person’s Form 3.
    • F3: Private placement warrants (if applicable to these awards) become exercisable 30 days after the initial business combination and expire five years after that event (or earlier upon liquidation).
  • Timeliness: The Form 4 was filed on 2026-05-05. The March 2 and March 18 awards were reported late (filed well after the 2-business-day rule); the May 1 award appears to have been filed within the usual 2-business-day window.

Context

  • These are derivative awards (convertible Class B shares and/or private placement warrants), not immediate sales. Class B shares typically convert into publicly traded Class A shares only upon the SPAC’s business combination; warrants typically have an exercise window that begins after that combination. Awards and grants are generally different from open-market purchases or sales and can reflect compensation, retention, or alignment with shareholders rather than direct market timing.
  • The late reporting of the March grants reduces near-term transparency; the SEC allows a short window for Form 4 filings and late reports can draw attention but do not by themselves indicate wrongdoing.

Insider Transaction Report

Form 4
Period: 2026-03-02
Epstein Jeffrey Douglas
DirectorPresident
Transactions
  • Award

    Class B Ordinary Shares

    [F1][F2]
    2026-03-02+450,000450,000 total
    Class A Ordinary Shares (450,000 underlying)
  • Award

    Class B Ordinary Shares

    [F1][F2]
    2026-03-18+150,000600,000 total
    Class A Ordinary Shares (150,000 underlying)
  • Award

    Warrant

    [F3]
    2026-05-01$1.00/sh+500,000$500,000500,000 total
    Exercise: $11.50Class A Ordinary Shares (500,000 underlying)
Footnotes (3)
  • [F1]The Class B Ordinary Shares will automatically convert into Class A Ordinary Shares at the time of the Issuer's initial business combination, or at any time prior thereto at the option of the Reporting Person, on a one-for-one basis, subject to adjustment, and have no expiration date.
  • [F2]These securities were previously reported on a Form 3 filed by the Reporting Person.
  • [F3]The private placement warrants will become exercisable 30 days after the completion of the Issuer's initial business combination and will expire five years after the completion of the Issuer's initial business combination or earlier upon liquidation.
Signature
/s/ Philip Kassin, Attorney-in-Fact|2026-05-05

Documents

1 file
  • 4
    ownership.xmlPrimary

    4